Dr Harold James Hebert, MD | |
510 Jefferson Terrace Blvd., Suite A, New Iberia, LA 70560-4046 | |
(337) 365-8161 | |
(337) 365-0294 |
Full Name | Dr Harold James Hebert |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 510 Jefferson Terrace Blvd., New Iberia, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275558462 | NPI | - | NPPES |
1145777 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 010900 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Harold James Hebert, MD 510 Jefferson Terrace Blvd., Suite A, New Iberia, LA 70560-4046 Ph: (337) 365-8161 | Dr Harold James Hebert, MD 510 Jefferson Terrace Blvd., Suite A, New Iberia, LA 70560-4046 Ph: (337) 365-8161 |
News Archive
A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.
Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures.
While the risks from ingesting chlorine bleach are clear, less obvious risks concerning airborne particles emanating from the bleach have been identified in a new study.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.
In what is believed to be the first study of its kind to demonstrate an association between the antidepressant escitalopram and improved general pain, researchers from Boston University School of Medicine (BUSM), have found that opioid-dependent patients treated with escitalopram experienced meaningful reductions in pain severity and pain interference during the first three months of therapy.
› Verified 5 days ago
Dr. Douglas A Bernard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 Jefferson Terrace Blvd, Suite A, New Iberia, LA 70560 Phone: 337-365-8161 Fax: 337-365-0294 | |
Dr. Edward J Lisecki, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 Jefferson Ter, Suite 100, New Iberia, LA 70560 Phone: 337-364-5310 Fax: 337-364-5313 | |
Dr. Kyle Allen Caswell, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 Jefferson Ter, Suite 100, New Iberia, LA 70560 Phone: 337-364-5310 | |
Dr. John C Osborne, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2308 E Main St Ste C, New Iberia, LA 70560 Phone: 337-369-1434 Fax: 337-369-1436 | |
Dr. William Andre' Cenac, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1307 Old Jeanerette Rd, Suite 100, New Iberia, LA 70563 Phone: 337-364-3000 Fax: 337-364-5333 | |
Dr. Seth Daniel Rosenzweig, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 N Lewis St, Suite 280, New Iberia, LA 70563 Phone: 337-367-1444 Fax: 337-367-1445 |